Expertise in
5
conditions

Dr. David M. Baratz

Pulmonary Associates PA
Phoenix, AZ
Expertise in
5
conditions
Specialties:Pulmonary Medicine | Sleep Medicine
Age:66
Accepting New Patients
Offers Telehealth
36 Years of Experience
Expertise in
5
conditions
OverviewInsuranceLocationsClinical Research

Overview

David Baratz is a Pulmonary Medicine specialist and a Sleep Medicine provider in Phoenix, Arizona. Dr. Baratz has been practicing medicine for over 36 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Narcolepsy, Obstructive Sleep Apnea, Pulmonary Hypertension, and Pneumonia. Dr. Baratz is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Sleep Medicine
Licenses
Sleep Medicine in AZ
Hospital Affiliations
Honorhealth Deer Valley Medical Center
Honor Health John C. Lincoln Medical Center
Languages Spoken
English
Russian
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Medica
  •  Oscar
  •  Humana

Locations

PULMONARY ASSOCIATES PA
3811 E Bell Rd, Suite 107, Phoenix, AZ 85032
602-340-1689

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Completed
Publish Date: April 19, 2023
Intervention Type: Drug, Other
Study Drug: Sotatercept
Study Phase: Phase 2
A Randomized, Phase 2, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Belumosudil in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Randomized, Phase 2, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Belumosudil in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Other, Drug
Study Drug: KD025
Study Phase: Phase 2
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis.
A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: September 22, 2023
Similar Doctors
Expertise in
10
conditions
Dr. Kenneth S. Knox
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Expertise in
10
conditions
Dr. Kenneth S. Knox
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Banner - University Physician Specialists LLC

755 E Mcdowell Rd, 
Phoenix, AZ 
 (12.6 mi)
602-521-3086
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth Knox is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Phoenix, Arizona. Dr. Knox is highly rated in 10 conditions, according to our data. His top areas of expertise are Coccidioidomycosis, Sarcoidosis, Pneumonia, Acute Interstitial Pneumonia, and Lung Transplant. Dr. Knox is currently accepting new patients.

Expertise in
22
conditions
Dr. Rajat Walia
Pulmonary Medicine | Intensive Care Medicine
Expertise in
22
conditions
Dr. Rajat Walia
Pulmonary Medicine | Intensive Care Medicine

Sjhmc Physician Services

500 W Thomas Rd, 680 Dhmg St Joseph's Pelvic Pain And Surg, 
Phoenix, AZ 
 (12.0 mi)
602-406-6017
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajat Walia is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Phoenix, Arizona. Dr. Walia is highly rated in 22 conditions, according to our data. His top areas of expertise are Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Tissue Biopsy. Dr. Walia is currently accepting new patients.

Expertise in
6
conditions
Dr. Chad M. Ruoff
Sleep Medicine
Expertise in
6
conditions
Dr. Chad M. Ruoff
Sleep Medicine

Mayo Clinic Arizona

5779 E Mayo Blvd, Speciality Building, 
Phoenix, AZ 
 (2.8 mi)
480-301-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Chad Ruoff is a Sleep Medicine provider in Phoenix, Arizona. Dr. Ruoff is highly rated in 6 conditions, according to our data. His top areas of expertise are Drowsiness, Narcolepsy, Obstructive Sleep Apnea, and Excessive Daytime Sleepiness. Dr. Ruoff is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile